Tatiana Mokhort

Prof. Tatiana Mokhort

Belarusian State Medical University, Minsk, Belarus
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
Pawel PludowskiPawel Pludowski
Pawel Pludowski
ITIstvan Takacs
Istvan Takacs
MBMihail Boyanov
Mihail Boyanov
ZBZhanna Belaya
Zhanna Belaya
Camelia DiaconuCamelia Diaconu
Camelia Diaconu
Stefan PilzStefan Pilz
Stefan Pilz
Vitamin D deficiency has a high worldwide prevalence, but actions to improve this public health problem are challenged by the heterogeneity of nutritional and clinical vitamin D guidelines, with respect to the diagnosis and treatment of vitamin D deficiency. We aimed to address this issue by providing respective recommendations for adults, developed by a European expert panel, using the Delphi method to reach consensus. Increasing the awareness of vitamin D deficiency and efforts to harmonize vitamin D guidelines should be pursued. We argue against a general screening for vitamin D deficiency but suggest 25-hydroxyvitamin D (25(OH)D) testing in certain risk groups. We recommend a vitamin D supplementation dose of 800 to 2000 international units (IU) per day for adults who want to ensure a sufficient vitamin D status. These doses are also recommended for the treatment of vitamin D deficiency, but higher vitamin D doses (e.g., 6000 IU per day) may be used for the first 4 to 12 weeks of treatment if a rapid correction of vitamin D deficiency is clinically indicated before continuing, with a maintenance dose of 800 to 2000 IU per day. Treatment success may be evaluated after at least 6 to 12 weeks in certain risk groups (e.g., patients with malabsorption syndromes) by measurement of serum 25(OH)D, with the aim to target concentrations of 30 to 50 ng/mL (75 to 125 nmol/L).

17 June 2018 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
TMTatiana Mokhort
Tatiana Mokhort
NKNatalia D. Kolomiets
Natalia D. Kolomiets
SPSergei V. Petrenko
Sergei V. Petrenko
EFEkaterina V. Fedorenko
Ekaterina V. Fedorenko
AMAlena G. Mokhort
Alena G. Mokhort
КДКоломиец Наталья Дмитриевна
Коломиец Наталья Дмитриевна
The strategy for elimination of iodine deficiency in the population was developed and implemented in the Republic of Belarus. It is based on acceptance of recommendations that iodized salt is a unique source of iodine support. Currently, adequate iodine consumption is achieved. The prevalence of thyroid gland diseases caused by iodine deficiency was significantly decreased. In 2013, the International Council for Control of Iodine Deficiency Disorders (ICCIDD), a global non-profit non-governmental organization established to eliminate iodine deficiency and its negative consequences, published the results of iodine status assessment in the world. According to these data, the Republic of Belarus provides adequate iodine intake. In 2016, Iodine Global Network published maps characterizing iodine supply for the two main categories — school-age children and pregnant females. These data have confirmed that the Republic of Belarus refers to countries with sufficient iodine consumption according to the results of subnational studies. Despite the achieved successes, new issues are raised: quality of iodine sufficiency monitoring, risks of excessive salt intake, and need for new approaches to diagnosing thyroid pathology due to iodine deficiency.

27 December 2018 in Clinical and experimental thyroidology
Verified
Journal Article
Open access
TMTatiana Mokhort
Tatiana Mokhort
SPSergei V. Petrenko
Sergei V. Petrenko
BLBoris Y. Leushev
Boris Y. Leushev
EFEkaterina V. Fedorenko
Ekaterina V. Fedorenko
NKNatalia D. Kolomiets
Natalia D. Kolomiets
AMAlena G. Mokhort
Alena G. Mokhort
Background. Despite the measures taken by the Government of Belarus, the problem of iodine deficiency among the population remains actual. Aims. To determine iodine sufficiency in children and pregnant women living in Belarus. Materials and methods. The study included 873 schoolchildren aged 9–12 years of both sexes, of which 650 children were in regular schools, and the remaining children in boarding schools. A separate group consisted of 700 practically healthy pregnant women (during gestation from 16 to 36 weeks). Questioning, determination of urinary iodine concentration and thyroid volume with ultrasound was carried out. Results. Urine iodine median was 191 µg/L in the 873 children in 16 regions of Belarus. Thyroid volume corresponds to the normative values in children. According to the survey, 81% of households used iodized salt, constantly – 46%. Indicator of iodine sufficiency of 700 pregnant women (median urinary iodine concentration was 121 µg /l) is a non-optimal for this population group. Conclusions. Currently adequate iodine supplementation in school age children has been achieved. The prevalence of thyroid gland diseases caused by iodine deficiency in children decreased significantly. In pregnant women iodine supply is still insufficient.

29 January 2024 in Journal of Renal Injury Prevention
Verified
Journal Article
Open access
VVVolha Vasilkova
Volha Vasilkova
IPIvan Pchelin
Ivan Pchelin
VBValentina Bayrasheva
Valentina Bayrasheva
NKNatalia Khudyakova
Natalia Khudyakova
ISIrina Savasteeva
Irina Savasteeva
TMTatiana Mokhort
Tatiana Mokhort
Introduction: A Diabetes mellitus (DM) and chronic kidney disease (CKD) are two chronic non-communicable diseases that have exceeded epidemic thresholds in all countries of the world. The problem of early diagnosis, prevention and treatment of CKD continues to be relevant for modern medicine, and assessment of the severity of CKD and associated cardiovascular complications is of great practical importance for primary and secondary prevention. Objectives: The aim of the study was to assess the role of proinflammatory cytokines, chemokines and growth factors in progression of CKD in patients with DM. Patients and Methods: We screened 155 type 2 DM patients aged 65.00 (55.00-71.00) years. Control group included 21 healthy people with the same age. Renal function was assessed based on the levels of serum creatinine, cystatin C, estimated glomerular filtration rate (eGFR), which was calculated according to the CKD-EPI (chronic kidney disease epidemiology collaboration) equation, and albuminuria, which was assessed as albumin/creatinine ratio (A/C). The analysis of serum and urine biomarkers was carried out by enzyme immunoassay using commercial test systems. Results: Patients with DM had significantly higher levels of proinflammatory cytokines in comparison with the control group. The levels of interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), vascular endothelial growth factor A (VEGF-A), fibroblast growth factor-23 (FGF-23), regulated upon activation, normal T cell expressed and presumably secreted (RANTES), MIG, CRP, kidney injury molecule-1 (KIM-1) and homocysteine gradually increased with decreasing GFR. According to the results of univariate linear regression analysis, there were significant relationships between the levels of VEGF-A, FGF-23, RANTES, tumor necrosis factor alpha (TNF-alpha), MIG, CRP, hs-CRP, IL-6 and renal function. By multiple linear regression analysis adjusted for confounding factors, serum creatinine was significantly correlated with FGF-23 (β=0.40, P<0.001) and Il-6 (β=0.29, P<0.001). Conclusion: Our study demonstrated the important role of growth factors and proinflammatory cytokines in the development and progression of CKD in DM. However, despite these data, the pathogenesis of diabetic changes in the kidneys remains not fully understood and, in order to clarify the possibility of pathogenetic influences on the progression of diabetic nephropathy, it is necessary to study various aspects of its development, including genetic factors.

10 March 2020 in Journal of Renal Injury Prevention
Verified
Journal Article
Open access
PDF file
VVVolha Vasilkova
Volha Vasilkova
TMTatiana Mokhort
Tatiana Mokhort
IPIvan Pchelin
Ivan Pchelin
VBValentina Bayrasheva
Valentina Bayrasheva
ENElena P. Naumenko
Elena P. Naumenko
NFNatallia A. Filiptsova
Natallia A. Filiptsova
Introduction: Insulin-like growth factor-1 (IGF-1) is a potent mitogen for glomerular mesangial cells which can stimulate cell migration and the production of fibronectin, proteoglycan, and type IV collagen, thereby promoting the development of the chronic kidney disease (CKD) in patients with diabetes. Objectives: The aim of the study was to assess the associations between serum levels of IGF-1 and insulin-like growth factor-binding protein-3 (IGFBP-3) and CKD in diabetic patients. Patients and Methods: We investigated 102 Belarusian men and women with diabetes type 2 aged 56.67±0.81 years. Control group included 68 healthy people the same age. We estimated GFR with the use of the CKD-EPI creatinine-cystatin C equation to determine eGFRcr_cys. Serum total IGF-1 and IGFBP-3 levels were measured using immunoradiometric assay (IRMA) (Beckman Coulter, Czech Republic s.r.o.). Results: Patients with diabetes had significantly lower level of IGF-1 than controls. However, IGFBP-3 levels were similar in the two groups. Diabetic patients with CKD had significantly higher levels of IGF-1 and IGFBP-3 than diabetic patients without CKD (P=0.0031). However, according to multivariate analysis, only IGF-1 and cystatin C were associated with renal impairment. In detail, the odds of having eGFR<60 mL/min/1.73 m2 increased with rising IGF-1 levels (OR: 1.025, [CI 1.002-1.048]). Conclusion: Our study revealed that higher serum IGF-1 levels were positively associated with CKD in patients with diabetes. We suggest that IGF-1 might be a predictor of CKD in patients with diabetes. Further research is necessary to confirm the observed this association and to detect the causal relations.

9 August 2022 in Osteoporosis and Bone Diseases
Verified
Journal Article
Open access
PDF file
NKN. V. Karlovich
N. V. Karlovich
TMTatiana Mokhort
Tatiana Mokhort
ASA. G. Sazonava
A. G. Sazonava
ЕСЕ. Г. Сазонова
Е. Г. Сазонова
The article presents current data on mineral and bone disorders in patients with various stages of chronic kidney disease. The key points of bone lesions pathology are reflected, which include impaired secretion of parathyroid hormone and phosphorus-calcium metabolism, specific osteopathy and extraskeletal calcification, the relationship between bone pathology and cardiovascular complications is indicated. The role of diagnostic tools (FRAX questionnaire, bone densitometry, biochemical parameters and new biological markers) is discussed, approaches to the interpretation of research results are defined. Both general population and specific risk factors for bone strength decrease and occurrence of osteoporotic fractures pathology in chronic kidney disease are described.